Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HM781-36B + paclitaxel + trastuzumab in HER2-positive advanced gastric cancer (phase I-II)
KCT0000606Phase 2Recruiting
- Sponsor
- Hanmi Pharmaceutical
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of poziotinib in gastric cancer (GC), sponsored by Hanmi Pharmaceutical. Started Dec 2012; status: recruiting.
02
Drugs
poziotinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0000606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000606.